drugset / Trial / NCT02237859
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
NaSingle-groupTriple-blindPrevention
Summary
We are doing this research study to determine if taking vancomycin in addition to a broad-spectrum antibiotic will decrease the chance of developing recurrent Clostridium difficile infection.
Timeline
- Start
- 2014-08
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vancomycin | Other / unclassified | 125 mg | Oral |